| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.8M | +3261.7% |
| Cost of Revenue | $3.1M | +7080.5% |
| Gross Profit | $2.7M | +1970.3% |
| R&D Expense | $1.4M | +70.1% |
| SG&A Expense | $6.8M | +332.7% |
| Operating Income | -$10.4M | -47.7% |
| Pre-tax Income | -$36.7M | -70.5% |
| Income Tax | $581 | +0.0% |
| Net Income | -$36.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.6M | +7111.0% |
| Inventory | $1.4M | +2093.0% |
| Current Assets | $6.4M | +537.6% |
| Total Assets | $10.7M | +245.4% |
| Current Liabilities | $8.1M | +266.3% |
| Total Liabilities | $10.5M | -61.8% |
| Stockholders' Equity | $239K | +101.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.3M | -302.8% |
| Capital Expenditures | $670K | — |
| Investing Cash Flow | -$1.8M | -119.3% |
| Financing Cash Flow | $15.2M | +259.1% |
| Free Cash Flow | -$13.9M | — |
| -70.5% |
| EPS (Basic) | -$1.78 | +0.0% |
| EPS (Diluted) | -$1.78 | +0.0% |